PI3K/PTEN/Akt/mTOR Pathway Aberrations and Co-Incidence of Hormone Receptors and HER2 in 19,784 Diverse Solid Tumors.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.15_suppl.11042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

Mp37-15 Pi3k-Akt-Mtor Pathway in Penile Squamous Cell Carcinoma: Clinical Significance of Pten, Akt and S6 Expression

Journal of Urology
Urology
2018English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

MicroRNAs and the PTEN/PI3K/Akt Pathway in Gastric Cancer (Review)

Oncology Reports
MedicineCancer ResearchOncology
2019English

Combinatorial Antitumor Effect of HDAC and the PI3K-Akt-mTOR Pathway Inhibition in a Pten Defecient Model of Prostate Cancer

Oncotarget
Oncology
2013English

PI3K/PTEN/Akt and TSC/mTOR Signaling Pathways, Ovarian Dysfunction, and Infertility: An Update

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2014English

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

Effect of PI3K/Akt/mTOR Signaling Pathway on JNK3 in Parkinsonian Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy